mAb Formulation

Showing 1–12 of 18 results

• 
  Biological Drug Product

  Adalimumab (Humira®) biosimilar

• 
  Biological Drug Product

  adalimumab biosimilar

  Approved by UK MHRA

• 
  Biological Drug Product

  Bevacizumab (Avastin®) biosimilar

• 
  API

  Bevacizumab (BAT1706/AVZIVI®)

• 
  Biological Drug Product

  bevacizumab biosimilar

  Approved by US FDA

• 
  Biological Drug Product

  Dupilumab

• 
  Biological Drug Product

  Dupilumab (Dupixent®) biosimilar

• 
  Biological Drug Product

  Golimumab

• 
  Biological Drug Product

  Golimumab (Simponi®) biosimilar

• 
  Biological Drug Product

  Mepolizumab

• 
  Biological Drug Product

  Mepolizumab (Nucala®) biosimilar

• 
  Biological Drug Product

  Secukinumab